Saturday 7 November 2026 Export AGIO’s income statement to Excel — free account

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $54.0 million, up 48.0% from fiscal 2024.

Revenue: +330.0%
EPS: +38.8%
Free cash flow: +32.6%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

29.41 1.14 +4.03%

Follow AGIO

Alert me

Market cap: $1.7B
P/E: 0.0×
Fwd P/E: −5.1×
Dividend yield: —
F-score: 3/9
Altman Z: 8.12
Beneish M: −1.72
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	14.10	22.45	30.11	29.21
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(33.51)	(38.52)	(16.72)	(16.40)
P/B ratio Full definition →	2.03	2.15	1.79	1.32
Price to Tangible BV Full definition →	2.03	2.15	1.79	1.32
EV/Sales Full definition →	9.62	16.17	18.95	13.40
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(4.09)	(4.41)	(3.29)	(1.94)
EV/FCF Full definition →	(4.03)	(4.35)	(3.25)	(1.92)
Quick Ratio Full definition →	8.12	9.08	12.80	10.52
Current Ratio Full definition →	9.69	10.22	14.19	11.46
Net Debt/EBITDA Full definition →	8.22	5.60	6.71	7.00
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.12	0.08	0.05	0.04
Operating CF/Net income Full definition →	0.91	0.57	1.20	0.89
Capex/Depreciation Full definition →	(2.23)	(5.43)	(3.51)	2.30
Research and Development Expense of Revenue Full definition →	132.68%	225.17%	391.15%	441.01%
Selling, General and Administrative Expense of Revenue Full definition →	102.07%	115.20%	232.84%	258.48%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	30.10%	35.63%	74.91%	70.74%
Graham Net Nets Full definition →	0.34	0.29	0.38	0.53
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(19.01%)	(18.89%)	(21.43%)	(26.12%)
Free Cash Flow Yield Full definition →	(16.92%)	(16.54%)	(19.35%)	(23.91%)
Revenue per Share Full definition →	0.93	0.75	0.35	0.34
Operating CF per Share Full definition →	(0.99)	(0.96)	(2.02)	(1.66)
Capex per Share Full definition →	(0.02)	(0.02)	(0.01)	(0.02)
Free Cash Flow per Share Full definition →	(1.01)	(0.98)	(2.04)	(1.68)
Cash per Share Full definition →	10.55	10.38	12.54	14.74
Shareholders Equity per Share Full definition →	16.40	17.25	18.87	20.58
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	16.40	17.25	18.87	20.58
Free Cash Flow Full definition →	(60.42)	(58.52)	(119.69)	(97.33)
Working Capital Full definition →	674.51	647.45	776.00	859.85
Capital Expenditures Full definition →	(1.18)	(1.21)	(0.77)	(1.12)
Net Current Asset Value Full definition →	667.39	635.27	758.97	837.94
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.02	0.03	0.04	0.06
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	—	12.55	9.74	7.34
Average Payables Full definition →	19.74	16.94	13.74	17.50
Average Inventory Full definition →	—	30.50	32.35	30.27
Average Assets Full definition →	1,224.87	1,289.83	1,370.25	1,480.21
Average Common Equity Full definition →	1,131.83	1,197.79	1,287.82	1,367.04

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly